These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 32065117)
1. Huai Qi Huang Potentiates Dexamethasone-Mediated Lethality in Acute Lymphoblastic Leukemia Cells by Upregulating Glucocorticoid Receptor α. Xu W; Wang Z; Li K; Jin R Med Sci Monit; 2020 Feb; 26():e921649. PubMed ID: 32065117 [TBL] [Abstract][Full Text] [Related]
2. Huai Qi Huang-induced Apoptosis via Down-regulating PRKCH and Inhibiting RAF/MEK/ERK Pathway in Ph Xu WF; Wang ZJ; Li K; Shen YQ; Lu K; Lv XY; Wen YX; Jin RM Curr Med Sci; 2020 Apr; 40(2):354-362. PubMed ID: 32337697 [TBL] [Abstract][Full Text] [Related]
3. Huang Qi Huai Granules Induce Apoptosis in Acute Lymphoblastic Leukemia Cells through the Akt/FoxO1 Pathway. Han J; Lin M; Zhou D; Zhang Z; Jin R; Zhou F Cell Physiol Biochem; 2016; 38(5):1803-14. PubMed ID: 27160160 [TBL] [Abstract][Full Text] [Related]
4. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor. Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130 [TBL] [Abstract][Full Text] [Related]
5. MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM. Rambal AA; Panaguiton ZL; Kramer L; Grant S; Harada H Leukemia; 2009 Oct; 23(10):1744-54. PubMed ID: 19404317 [TBL] [Abstract][Full Text] [Related]
6. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells]. He L; Li D; Hou KZ; Liu YP Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564 [TBL] [Abstract][Full Text] [Related]
7. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children. Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223 [TBL] [Abstract][Full Text] [Related]
8. Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines. Wang XW; Xu YH Genet Mol Res; 2015 Jul; 14(3):7883-93. PubMed ID: 26214469 [TBL] [Abstract][Full Text] [Related]
9. Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members. Laane E; Panaretakis T; Pokrovskaja K; Buentke E; Corcoran M; Söderhäll S; Heyman M; Mazur J; Zhivotovsky B; Porwit A; Grandér D Haematologica; 2007 Nov; 92(11):1460-9. PubMed ID: 18024393 [TBL] [Abstract][Full Text] [Related]
10. CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response. Dixon ZA; Nicholson L; Zeppetzauer M; Matheson E; Sinclair P; Harrison CJ; Irving JA Haematologica; 2017 Apr; 102(4):736-745. PubMed ID: 27979926 [TBL] [Abstract][Full Text] [Related]
11. Pyr3, a TRPC3 channel blocker, potentiates dexamethasone sensitivity and apoptosis in acute lymphoblastic leukemia cells by disturbing Ca(2+) signaling, mitochondrial membrane potential changes and reactive oxygen species production. Abdoul-Azize S; Buquet C; Vannier JP; Dubus I Eur J Pharmacol; 2016 Aug; 784():90-8. PubMed ID: 27179991 [TBL] [Abstract][Full Text] [Related]
12. Diversity of the apoptotic response to chemotherapy in childhood leukemia. Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289 [TBL] [Abstract][Full Text] [Related]
13. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression. Medh RD; Saeed MF; Johnson BH; Thompson EB Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879 [TBL] [Abstract][Full Text] [Related]
14. Effect of EPA on Hsp90 and GRα protein expression in multiple myeloma drug-resistant cells. Wu S; Chen Y; Wang X; Weng S; Zhou W; Liu Z BMC Cancer; 2021 Oct; 21(1):1076. PubMed ID: 34600510 [TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum stress, unfolded protein response and autophagy contribute to resistance to glucocorticoid treatment in human acute lymphoblastic leukaemia cells. Sudsaward S; Khunchai S; Thepmalee C; Othman A; Limjindaporn T; Yenchitsomanus PT; Mutti L; Krstic-Demonacos M; Demonacos C Int J Oncol; 2020 Sep; 57(3):835-844. PubMed ID: 32705154 [TBL] [Abstract][Full Text] [Related]
16. Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia. Bongiovanni D; Tosello V; Saccomani V; Dalla Santa S; Amadori A; Zanovello P; Piovan E Oncogene; 2020 Oct; 39(42):6544-6555. PubMed ID: 32917954 [TBL] [Abstract][Full Text] [Related]
17. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor. Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002 [TBL] [Abstract][Full Text] [Related]
18. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK. Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985 [TBL] [Abstract][Full Text] [Related]